http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 28 May 2026 09:20:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PRF+Technologies+Ltd.+++++For%3A+May+28/26562464.html si-local-file:///var/storage/secattach/20260528/26562464.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PRF+Technologies+Ltd.+++++For%3A+May+28/26562464.html Thu, 28 May 2026 09:20:00 -0400 O.13796267 PRFX http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PRF+Technologies+Ltd.+++++For%3A+May+28/26562464.html si-local-file:///var/storage/secattach/20260528/26562464.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PRF+Technologies+Ltd.+++++For%3A+May+28/26562464.html Thu, 28 May 2026 09:20:00 -0400 O.13796267 PRFX http://www.streetinsider.com/Corporate+News/PRF+Technologies+advances+AI+platform+for+renewable+energy+optimization/26561735.html <p>PRF Technologies Ltd. (NASDAQ: PRFX) announced progress on its DeepSolar Predict platform, an AI-driven system designed for renewable energy revenue optimization. The company is preparing the platform for commercial launch.</p> <p>DeepSolar Predict combines AI forecasting, storage intelligence and market-driven decision support to help renewable energy operators optimize revenue in real-time. The platform targets solar, wind and battery energy storage assets.</p> <p>The system includes localized weather intelligence for production forecasting, imbalance risk management tools, storage optimization capabilities, portfolio-level analytics and real-time market decision support. PRF states the platform addresses challenges including weather variability, production uncertainty, imbalance penalties and grid constraints.</p> <p>"Renewable energy operators are http://www.streetinsider.com/Corporate+News/PRF+Technologies+advances+AI+platform+for+renewable+energy+optimization/26561735.html Thu, 28 May 2026 08:30:46 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Corporate+News/PRF+Technologies+advances+AI+platform+for+renewable+energy+optimization/26561735.html <p>PRF Technologies Ltd. (NASDAQ: PRFX) announced progress on its DeepSolar Predict platform, an AI-driven system designed for renewable energy revenue optimization. The company is preparing the platform for commercial launch.</p> <p>DeepSolar Predict combines AI forecasting, storage intelligence and market-driven decision support to help renewable energy operators optimize revenue in real-time. The platform targets solar, wind and battery energy storage assets.</p> <p>The system includes localized weather intelligence for production forecasting, imbalance risk management tools, storage optimization capabilities, portfolio-level analytics and real-time market decision support. PRF states the platform addresses challenges including weather variability, production uncertainty, imbalance penalties and grid constraints.</p> <p>"Renewable energy operators are http://www.streetinsider.com/Corporate+News/PRF+Technologies+advances+AI+platform+for+renewable+energy+optimization/26561735.html Thu, 28 May 2026 08:30:46 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Corporate+News/PRF+Technologies+advances+AI+platform+for+renewable+energy+optimization/26561735.html <p>PRF Technologies Ltd. (NASDAQ: PRFX) announced progress on its DeepSolar Predict platform, an AI-driven system designed for renewable energy revenue optimization. The company is preparing the platform for commercial launch.</p> <p>DeepSolar Predict combines AI forecasting, storage intelligence and market-driven decision support to help renewable energy operators optimize revenue in real-time. The platform targets solar, wind and battery energy storage assets.</p> <p>The system includes localized weather intelligence for production forecasting, imbalance risk management tools, storage optimization capabilities, portfolio-level analytics and real-time market decision support. PRF states the platform addresses challenges including weather variability, production uncertainty, imbalance penalties and grid constraints.</p> <p>"Renewable energy operators are http://www.streetinsider.com/Corporate+News/PRF+Technologies+advances+AI+platform+for+renewable+energy+optimization/26561735.html Thu, 28 May 2026 08:30:46 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Corporate+News/PRF+Technologies+advances+AI+platform+for+renewable+energy+optimization/26561735.html <p>PRF Technologies Ltd. (NASDAQ: PRFX) announced progress on its DeepSolar Predict platform, an AI-driven system designed for renewable energy revenue optimization. The company is preparing the platform for commercial launch.</p> <p>DeepSolar Predict combines AI forecasting, storage intelligence and market-driven decision support to help renewable energy operators optimize revenue in real-time. The platform targets solar, wind and battery energy storage assets.</p> <p>The system includes localized weather intelligence for production forecasting, imbalance risk management tools, storage optimization capabilities, portfolio-level analytics and real-time market decision support. PRF states the platform addresses challenges including weather variability, production uncertainty, imbalance penalties and grid constraints.</p> <p>"Renewable energy operators are http://www.streetinsider.com/Corporate+News/PRF+Technologies+advances+AI+platform+for+renewable+energy+optimization/26561735.html Thu, 28 May 2026 08:30:46 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Press+Releases/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html <p align="justify">TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong> today provided an update on the advancement of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch.</p> <p align="justify">DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform.</p> <p align="justify">DeepSolar Predict is being developed with the goal of helping renewable asset owners, http://www.streetinsider.com/Press+Releases/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html Thu, 28 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Press+Releases/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html <p align="justify">TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong> today provided an update on the advancement of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch.</p> <p align="justify">DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform.</p> <p align="justify">DeepSolar Predict is being developed with the goal of helping renewable asset owners, http://www.streetinsider.com/Press+Releases/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html Thu, 28 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Press+Releases/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html <p align="justify">TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong> today provided an update on the advancement of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch.</p> <p align="justify">DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform.</p> <p align="justify">DeepSolar Predict is being developed with the goal of helping renewable asset owners, http://www.streetinsider.com/Press+Releases/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html Thu, 28 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Press+Releases/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html <p align="justify">TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong> today provided an update on the advancement of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch.</p> <p align="justify">DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform.</p> <p align="justify">DeepSolar Predict is being developed with the goal of helping renewable asset owners, http://www.streetinsider.com/Press+Releases/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html Thu, 28 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html <p align="justify">TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong> today provided an update on the advancement of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch.</p> <p align="justify">DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform.</p> <p align="justify">DeepSolar Predict is being developed with the goal of helping renewable asset owners, http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html Thu, 28 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html <p align="justify">TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong> today provided an update on the advancement of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch.</p> <p align="justify">DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform.</p> <p align="justify">DeepSolar Predict is being developed with the goal of helping renewable asset owners, http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html Thu, 28 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html <p align="justify">TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong> today provided an update on the advancement of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch.</p> <p align="justify">DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform.</p> <p align="justify">DeepSolar Predict is being developed with the goal of helping renewable asset owners, http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html Thu, 28 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html <p align="justify">TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong> today provided an update on the advancement of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch.</p> <p align="justify">DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform.</p> <p align="justify">DeepSolar Predict is being developed with the goal of helping renewable asset owners, http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Advances+DeepSolar+Predict%E2%84%A2+Toward+Commercial+Launch+as+AI+Platform+Targets+Revenue+Optimization+Across+Renewable+Energy+Markets/26561729.html Thu, 28 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PRF+Technologies+Ltd.+++++For%3A+May+26/26546571.html si-local-file:///var/storage/secattach/20260526/26546571.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PRF+Technologies+Ltd.+++++For%3A+May+26/26546571.html Tue, 26 May 2026 08:42:00 -0400 O.13796267 PRFX http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PRF+Technologies+Ltd.+++++For%3A+May+26/26546571.html si-local-file:///var/storage/secattach/20260526/26546571.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PRF+Technologies+Ltd.+++++For%3A+May+26/26546571.html Tue, 26 May 2026 08:42:00 -0400 O.13796267 PRFX http://www.streetinsider.com/Corporate+News/PRF+Technologies+reports+comparable+pain+relief+in+preclinical+study/26546493.html <p>PRF Technologies Ltd. (NASDAQ: PRFX) announced results from a preclinical study comparing its drug candidate PRF-110 to an approved pain medication in domestic pigs. The study found PRF-110 provided sustained pain relief comparable to ZYNRELEF over a 72-hour period following surgery.</p><p>PRF-110 is an extended-release formulation of ropivacaine designed to be applied directly to surgical wounds before closure. The company is developing the product to provide prolonged local pain relief after surgery through a single administration, with the goal of reducing opioid use for post-surgical pain management.</p><p>In the head-to-head study, both PRF-110 and ZYNRELEF produced reductions in pain-related measures in a http://www.streetinsider.com/Corporate+News/PRF+Technologies+reports+comparable+pain+relief+in+preclinical+study/26546493.html Tue, 26 May 2026 08:31:09 -0400 PRFX http://www.streetinsider.com/FDA/PRF+Technologies+reports+comparable+pain+relief+in+preclinical+study/26546493.html <p>PRF Technologies Ltd. (NASDAQ: PRFX) announced results from a preclinical study comparing its drug candidate PRF-110 to an approved pain medication in domestic pigs. The study found PRF-110 provided sustained pain relief comparable to ZYNRELEF over a 72-hour period following surgery.</p><p>PRF-110 is an extended-release formulation of ropivacaine designed to be applied directly to surgical wounds before closure. The company is developing the product to provide prolonged local pain relief after surgery through a single administration, with the goal of reducing opioid use for post-surgical pain management.</p><p>In the head-to-head study, both PRF-110 and ZYNRELEF produced reductions in pain-related measures in a http://www.streetinsider.com/FDA/PRF+Technologies+reports+comparable+pain+relief+in+preclinical+study/26546493.html Tue, 26 May 2026 08:31:09 -0400 PRFX http://www.streetinsider.com/Press+Releases/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html <p align="justify">TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong>, a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, today announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110, to ZYNRELEF® (bupivacaine and meloxicam extended-release solution), an approved extended-release product used as a benchmark in the study.</p> <p align="justify">PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine designed to be deposited directly into the surgical wound bed prior to closure. The product candidate http://www.streetinsider.com/Press+Releases/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html Tue, 26 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Press+Releases/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html <p align="justify">TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong>, a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, today announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110, to ZYNRELEF® (bupivacaine and meloxicam extended-release solution), an approved extended-release product used as a benchmark in the study.</p> <p align="justify">PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine designed to be deposited directly into the surgical wound bed prior to closure. The product candidate http://www.streetinsider.com/Press+Releases/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html Tue, 26 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Press+Releases/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html <p align="justify">TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong>, a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, today announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110, to ZYNRELEF® (bupivacaine and meloxicam extended-release solution), an approved extended-release product used as a benchmark in the study.</p> <p align="justify">PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine designed to be deposited directly into the surgical wound bed prior to closure. The product candidate http://www.streetinsider.com/Press+Releases/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html Tue, 26 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Press+Releases/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html <p align="justify">TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong>, a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, today announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110, to ZYNRELEF® (bupivacaine and meloxicam extended-release solution), an approved extended-release product used as a benchmark in the study.</p> <p align="justify">PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine designed to be deposited directly into the surgical wound bed prior to closure. The product candidate http://www.streetinsider.com/Press+Releases/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html Tue, 26 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html <p align="justify">TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong>, a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, today announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110, to ZYNRELEF® (bupivacaine and meloxicam extended-release solution), an approved extended-release product used as a benchmark in the study.</p> <p align="justify">PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine designed to be deposited directly into the surgical wound bed prior to closure. The product candidate http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html Tue, 26 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html <p align="justify">TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong>, a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, today announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110, to ZYNRELEF® (bupivacaine and meloxicam extended-release solution), an approved extended-release product used as a benchmark in the study.</p> <p align="justify">PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine designed to be deposited directly into the surgical wound bed prior to closure. The product candidate http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html Tue, 26 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html <p align="justify">TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- <strong>PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”)</strong>, a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, today announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110, to ZYNRELEF® (bupivacaine and meloxicam extended-release solution), an approved extended-release product used as a benchmark in the study.</p> <p align="justify">PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine designed to be deposited directly into the surgical wound bed prior to closure. The product candidate http://www.streetinsider.com/Globe+Newswire/PRF+Technologies+Announces+PRF-110+Demonstrated+Sustained+72-Hour+Analgesic+Activity+Comparable+to+Approved%2C+Commercially+Available+Benchmark+in+Head-to-Head+Preclinical+Study/26546468.html Tue, 26 May 2026 08:30:00 -0400 A.06261224 O.13793336 O.13796267 PRFX